参考文献/References:
[1] Pop-Busui R,Braffett BH,Zinman B,et al. Cardiovascular autonomic neuropathy and cardiovascular outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications(DCCT/EDIC)study[J].Diabetes Care,2017,40(1):94-100.DOI:10.2337/dc16-1397.
[2] Spallone V,Ziegler D,Freeman R,et al.Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management[J].Diabetes Metab Res Rev,2011,27(7):639-653.DOI:10.1002/dmrr.1239.
[3] Pop-Busui R,Boulton AJ,Feldman EL,et al.Diabetic neuropathy: a position statement by the American Diabetes Association[J].Diabetes Care,2017,40(1):136-154. DOI:10.2337/dc16-2042.
[4] Lin K,Wei L,Huang Z,et al.Combination of Ewing test, heart rate variability, and heart rate turbulence analysis for early diagnosis of diabetic cardiac autonomic neuropathy[J].Medicine(Baltimore),2017,96(45):e8296.DOI:10.1097/MD.0000000000008296.
[5] Brock C,Jessen N,Brock B,et al.Cardiac vagal tone, a non-invasive measure of parasympathetic tone, is a clinically relevant tool in type 1 diabetes mellitus[J].Diabet Med,2017,34(10):1428-1434.DOI:10.1111/dme.13421.
[6] Ziegler D,Voss A,Rathmann W,et al. Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey[J].Diabetologia,2015,58(5):1118-1128.DOI:10.1007/s00125-015-3534-7.
[7] Takase B,Kitamura H,Noritake M,et al.Assessment of diabetic autonomic neuropathy using twenty-four-hour spectral analysis of heart rate variability: a comparison with the findings of the Ewing battery[J].Jpn Heart J,2002,43(2):127-135.
[8] Kataoka M,Ito C,Sasaki H,et al.Low heart rate variability is a risk factor for sudden cardiac death in type 2 diabetes[J].Diabetes Res Clin Pract,2004,64(1):51-58.DOI:10.1016/j.diabres.2003.10.009.
[9] Pop-Busui R,Evans GW,Gerstein HC,et al.Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes(ACCORD)trial[J].Diabetes Care,2010,33(7):1578-1584.DOI:10.2337/dc10-0125.
[10] Ewing DJ,Martyn CN,Young RJ,et al. The value of cardiovascular autonomic function tests: 10 years experience in diabetes[J].Diabetes Care,1985,8(5):491-498.
[11] Körei AE,Kempler M,Istenes I,et al.Why not to use the handgrip test in the assessment of cardiovascular autonomic neuropathy among patients with diabetes mellitus[J].Curr Vasc Pharmacol,2017,15(1):66-73.DOI:10.2174/1570161114666160822154351.
[12] Stranieri A,Abawajy J,Kelarev A,et al.An approach for Ewing test selection to support the clinical assessment of cardiac autonomic neuropathy[J].Artif Intell Med,2013,58(3):185-193.DOI:10.1016/j.artmed.2013.04.007.
[13] Tesfaye S,Boulton AJ,Dyck PJ,et al.Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments[J].Diabetes Care,2010,33(10):2285-2293.DOI:10.2337/dc10-1303.
[14] Scholte AJ,Schuijf JD,Delgado V,et al.Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of 123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability[J].Eur J Nucl Med Mol Imaging,2010,37(9):1698-1705.DOI:10.1007/s00259-010-1442-0.
[15] Ang L,Jaiswal M,Callaghan B,et al.Sudomotor dysfunction as a measure of small fiber neuropathy in type 1 diabetes[J].Auton Neurosci,2017,205:87-92.DOI:10.1016/j.autneu.2017.03.001.
[16] Papanas N,Ziegler D.Corneal confocal microscopy: a new technique for early detection of diabetic neuropathy[J].Curr Diab Rep,2013,13(4):488-499.DOI:10.1007/s11892-013-0390-z.
[17] Maddaloni E,Sabatino F,Del Toro R,et al.In vivo corneal confocal microscopy as a novel non-invasive tool to investigate cardiac autonomic neuropathy in type 1 diabetes[J].Diabet Med,2015,32(2):262-266.DOI:10.1111/dme.12583.
[18] 王宏利,樊东升,王薇,等.角膜共焦显微镜对于糖尿病自主神经病变的早期诊断价值[J].中华医学杂志,2015(35):2851-2856. DOI:10.3760cma.j.issn.0376-2491.2015.35.009.
[19] Tavakoli M,Begum P, McLaughlin J,et al.Corneal confocal microscopy for the diagnosis of diabetic autonomic neuropathy[J].Muscle Nerve,2015,52(3):363-370. DOI:10.1002/mus.24553.
[20] Yang Z,Xu B,Lu J,et al.Autonomic test by EZSCAN in the screening for prediabetes and diabetes[J].PLoS One,2013,8(2):e56480.DOI:10.1371/journal.pone.0056480.
[21] Yajnik CS,Kantikar V,Pande A,et al. Screening of cardiovascular autonomic neuropathy in patients with diabetes using non-invasive quick and simple assessment of sudomotor function[J].Diabetes Metab,2013,39(2):126-131.DOI:10.1016/j.diabet.2012.09.004.
[22] Selvarajah D,Cash T,Davies J, et al.SUDOSCAN: a simple, rapid, and objective method with potential for screening for diabetic peripheral neuropathy[J].PLoS One,2015,10(10):e0138224.DOI:10.1371/journal.pone.0138224.
[23] Jin J,Wang W,Gu T,et al.The application of SUDOSCAN for screening diabetic peripheral neuropathy in Chinese population screening DPN by SUDOSCAN[J].Exp Clin Endocrinol Diabetes,2017.DOI:10.1055/s-0043-116673.
[24] Mendivil CO,Kattah W,Orduz A,et al.Neuropad for the detection of cardiovascular autonomic neuropathy in patients with type 2 diabetes[J].J Diabetes Complications,2016,30(1):93-98.DOI:10.1016/j.jdiacomp.2015.10.004.
[25] Quattrini C,Jeziorska M,Tavakoli M,et al.The Neuropad test: a visual indicator test for human diabetic neuropathy[J].Diabetologia,2008,51(6):1046-1050.DOI:10.1007/s00125-008-0987-y.
[26] Spallone V,Morganti R,Siampli M,et al.Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy[J].Diabet Med,2009,26(7):686-692.DOI:10.1111/j.1464-5491.2009.02760.x.